Clinical Study
The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients with Severe Sepsis: A Prospective Cohort Study
Table 3
The effect of esmolol on hemodynamics in patients with severe sepsis.
| (Time, H) | Esmolol group () Mean ± standard deviation | Control group () Mean ± standard deviation | | |
| Fluid intake | | | | | 24 h | 4373.36 ± 571.86 | 4841.75 ± 658.89 | −4.663 | <0.01 | 48 h | 4189.61 ± 515.52 | 4720.74 ± 648.60 | −5.566 | <0.01 | 72 h | 3991.08 ± 486.73 | 4553.20 ± 591.72 | −6.371 | <0.01 | HR | | | | | Base value | 125.04 ± 13.28 | 127.21 ± 13.88 | −0.982 | 0.328 | 24 h | 101.96 ± 7.36 | 110.12 ± 8.59 | −6.272 | <0.01 | 48 h | 93.04 ± 4.52 | 102.57 ± 6.91 | −10.039 | <0.01 | 72 h | 84.17 ± 6.26 | 94.47 ± 7.91 | −8.861 | <0.01 | MAP | | | | | Base value | 74.71 ± 7.28 | 75.89 ± 6.61 | −1.051 | 0.295 | 24 h | 68.65 ± 9.72 | 68.54 ± 7.69 | 0.080 | 0.936 | 48 h | 71.00 ± 11.80 | 68.39 ± 7.53 | 1.615 | 0.109 | 72 h | 70.91 ± 10.57 | 68.14 ± 7.73 | 1.829 | 0.069 | CVP | | | | | Base value | 12.45 ± 3.16 | 11.99 ± 3.35 | 0.881 | 0.380 | 24 h | 10.04 ± 1.72 | 10.04 ± 1.71 | 0.002 | 0.998 | 48 h | 10.08 ± 1.43 | 9.83 ± 1.23 | 1.158 | 0.249 | 72 h | 9.77 ± 1.60 | 9.91 ± 1.64 | −0.510 | 0.611 | IS | | | | | Base value | 10.99 ± 2.08 | 11.11 ± 1.81 | −0.374 | 0.709 | 24 h | 10.92 ± 1.39 | 10.74 ± 1.40 | 0.794 | 0.428 | 48 h | 9.56 ± 1.18 | 9.51 ± 1.44 | 0.243 | 0.808 | 72 h | 9.09 ± 1.24 | 9.29 ± 1.23 | −0.957 | 0.340 |
|
|